VERA THERAPEUTICS INC CLASS A (VERA)
NASDAQ • Healthcare
$32.28
+$0.65 (+2.1%)
Market open
Last close at August 18, 2026 at 20:00 UTC
Fundamentals Charts
About VERA THERAPEUTICS INC CLASS A
Name
VERA THERAPEUTICS INC CLASS A
CEO
Marshall Fordyce
Website
Industry
Healthcare
Year Founded
2016
Employees
339
Vera Therapeutics, Inc. is a NASDAQ-listed healthcare company in biotechnology that develops medicines for serious diseases. The company is a small-cap clinical-stage drug developer focused on two lead programs, atacicept and MAU868, and operates in the United States from a base in Brisbane, California.
Fundamentals & Financials
Revenue (TTM)
$0
Net Income (TTM)
-$401.8M
EPS (TTM)
-$5.86
ROA (TTM)
-75.4%
Current Ratio
10.92
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Stay Ahead of the Market
Get premium market insights delivered directly to your inbox.
Quote Summary
Previous CloseDay Range$32.28$31.31 - $32.35
52 Week RangeAvg. Volume$21.15 - $56.052.1M
Market Cap$2.3B
Peers & Related Assets
CLDXCELLDEX THERAPEUTICS INC
$41.79-0.3%
IMNMIMMUNOME INC
$27.56+0.6%
NUVBNUVATION BIO INC CLASS A
$6.96+7.4%
BHVNBIOHAVEN LTD
$13.57-6.2%
ABCLAbCellera Biologics Inc.
QUREuniQure N.V.
VRDNVIRIDIAN THERAPEUTICS ORS INC
PHVSPharvaris N.V.
HRMYHARMONY BIOSCIENCES HLDG INC
JANXJANUX THERAPEUTICS INC